Islet amyloid polypeptide gene: no evidence of abnormal promoter region in thirty-five type 2 diabetic patients
- 1 January 1994
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 22 (2-3) , 99-105
- https://doi.org/10.1016/0168-8227(94)90042-6
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
This publication has 20 references indexed in Scilit:
- Islet Amyloid Polypeptide/Amylin Contents in Pancreata Increase in Genetically Obese and Diabetic MiceHormone and Metabolic Research, 1993
- Islet amyloid polypeptide (IAPP) gene analysis in a Japanese diabetic with marked islet amyloid depositionDiabetes Research and Clinical Practice, 1992
- Islet amyliod polypeptide-derived amyloid deposition increases along with the duration of type 2 diabetes mellitusDiabetes Research and Clinical Practice, 1992
- IAPP/amylin gene transcriptional control region: evidence for negative regulationFEBS Letters, 1990
- The human islet amyloid polypeptide (IAPP) geneFEBS Letters, 1990
- Secretion of islet amyloid polypeptide in response to glucoseFEBS Letters, 1989
- Maturity‐onset diabetes of the young (MODY)Diabetes/Metabolism Research and Reviews, 1989
- The complete islet amyloid polypeptide precursor is encoded by two exonsFEBS Letters, 1989
- Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1989
- Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitroNature, 1988